Literature DB >> 26199031

Redox stress unbalances the inflammatory cytokine network: role in autoinflammatory patients and healthy subjects.

Rosa Lavieri1, Anna Rubartelli1, Sonia Carta2.   

Abstract

The cell stress and redox responses are increasingly acknowledged as factors contributing to the generation and development of the inflammatory response. Several inflammation-inducing stressors have been identified, inside and outside of the cell. Furthermore, many hereditary diseases associate with inflammation and oxidative stress, suggesting a role for mutated proteins as stressors. The nucleotide-binding oligomerization domain, leucine-rich repeat-containing family, pyrin domain-containing 3 (NLRP3) inflammasome is an important node at the crossroad between redox response and inflammation. Remarkably, monocytes from patients with mutations in the NLRP3 gene undergo oxidative stress after stimulation with minute amounts of TLR agonists, resulting in unbalanced production of IL-1β and regulatory cytokines. Similar alterations in cytokine production are found in healthy monocytes upon TLR overstimulation. This mini-review summarizes recent progress in this field, discusses the molecular mechanisms underlying the loss of control of the cytokine network following oxidative stress, and proposes new therapeutic opportunities. © Society for Leukocyte Biology.

Entities:  

Keywords:  ATP secretion; NLRP3 inflammasome; TLR agonist; interleukin-1 family

Mesh:

Substances:

Year:  2015        PMID: 26199031      PMCID: PMC4673480          DOI: 10.1189/jlb.3MR0415-159R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  80 in total

Review 1.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

Authors:  Eduardo R Lazarowski; Richard C Boucher; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 3.  Autoinflammatory diseases.

Authors:  Anna Rubartelli
Journal:  Immunol Lett       Date:  2014-01-19       Impact factor: 3.685

4.  Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1.

Authors:  Olaf Gross; Amir S Yazdi; Christina J Thomas; Mark Masin; Leonhard X Heinz; Greta Guarda; Manfredo Quadroni; Stefan K Drexler; Jurg Tschopp
Journal:  Immunity       Date:  2012-03-23       Impact factor: 31.745

5.  P2X7 receptors mediate ischemic damage to oligodendrocytes.

Authors:  Maria Domercq; Alberto Perez-Samartin; David Aparicio; Elena Alberdi; Olatz Pampliega; Carlos Matute
Journal:  Glia       Date:  2010-04-15       Impact factor: 7.452

Review 6.  Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.

Authors:  Toshio Tanaka; Masashi Narazaki; Tadamitsu Kishimoto
Journal:  FEBS Lett       Date:  2011-03-21       Impact factor: 4.124

7.  ATP release from non-excitable cells.

Authors:  Helle A Praetorius; Jens Leipziger
Journal:  Purinergic Signal       Date:  2009-03-20       Impact factor: 3.765

8.  Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance.

Authors:  Sonia Carta; Federica Penco; Rosa Lavieri; Alberto Martini; Charles Anthony Dinarello; Marco Gattorno; Anna Rubartelli
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

9.  ATP release and purinergic signaling in NLRP3 inflammasome activation.

Authors:  Aurélie Gombault; Ludivine Baron; Isabelle Couillin
Journal:  Front Immunol       Date:  2013-01-08       Impact factor: 7.561

10.  Paneth cells as a site of origin for intestinal inflammation.

Authors:  Timon E Adolph; Michal F Tomczak; Lukas Niederreiter; Hyun-Jeong Ko; Janne Böck; Eduardo Martinez-Naves; Jonathan N Glickman; Markus Tschurtschenthaler; John Hartwig; Shuhei Hosomi; Magdalena B Flak; Jennifer L Cusick; Kenji Kohno; Takao Iwawaki; Susanne Billmann-Born; Tim Raine; Richa Bharti; Ralph Lucius; Mi-Na Kweon; Stefan J Marciniak; Augustine Choi; Susan J Hagen; Stefan Schreiber; Philip Rosenstiel; Arthur Kaser; Richard S Blumberg
Journal:  Nature       Date:  2013-10-02       Impact factor: 49.962

View more
  6 in total

1.  Bone microRNA-21 as surgical stress parameter is associated with third molar postoperative discomfort.

Authors:  Milan Vucetic; Jelena Roganovic; Martin Freilich; David Shafer; Marija Milic; Ljiljana DJukic; Nina Petrovic; Evgenija Markovic; Aleksa Markovic; Bozidar Brkovic
Journal:  Clin Oral Investig       Date:  2020-06-04       Impact factor: 3.573

2.  Assessment of ultra-structure, viability and function of lipopolysaccharides-stimulated human dermal fibroblasts treated with chrysin and exosomes (in vitro study).

Authors:  Rabab Hassan; Dina Sabry; Amany A Rabea
Journal:  Saudi Dent J       Date:  2022-04-25

3.  Unconventional Transport Routes of Soluble and Membrane Proteins and Their Role in Developmental Biology.

Authors:  Andrea Pompa; Francesca De Marchis; Maria Teresa Pallotta; Yoselin Benitez-Alfonso; Alexandra Jones; Kerstin Schipper; Kevin Moreau; Viktor Žárský; Gian Pietro Di Sansebastiano; Michele Bellucci
Journal:  Int J Mol Sci       Date:  2017-03-25       Impact factor: 5.923

Review 4.  A myriad of roles of dendritic cells in atherosclerosis.

Authors:  Yanfang Zhao; Jing Zhang; Wenjie Zhang; Yuekang Xu
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 5.732

5.  Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome.

Authors:  Zi-Teng Zhang; Xiu-Ming Du; Xiu-Juan Ma; Ying Zong; Ji-Kuai Chen; Chen-Lin Yu; Yan-Gang Liu; Yong-Chun Chen; Li-Jun Zhao; Guo-Cai Lu
Journal:  J Neuroinflammation       Date:  2016-04-05       Impact factor: 8.322

6.  End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression.

Authors:  Ruijing Zhang; Jason Saredy; Ying Shao; Tian Yao; Lu Liu; Fatma Saaoud; William Y Yang; Yu Sun; Candice Johnson; Charles Drummer; Hangfei Fu; Yifan Lu; Keman Xu; Ming Liu; Jirong Wang; Elizabeth Cutler; Daohai Yu; Xiaohua Jiang; Yafeng Li; Rongshan Li; Lihua Wang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Redox Biol       Date:  2020-02-20       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.